Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Duraent Pharmaceuticals is a specialty pharmaceutical company headquartered in India, dedicated to the development and commercialization of branded generic medications and nutraceuticals. The company focuses on high-growth therapeutic areas including gastroenterology, orthopedics, gynecology, and pain management. Duraent's product portfolio is designed to provide effective and affordable treatment options for both chronic and acute conditions, such as acid reflux, inflammatory disorders, and nutritional deficiencies. By maintaining a robust distribution network and a commitment to quality, the company aims to improve patient access to essential medicines across the Indian market. Duraent continues to expand its presence by introducing specialized formulations that address unmet clinical needs in its core therapeutic segments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Duraent.